| Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... bmj 369, 2020 | 3337 | 2020 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1017 | 2021 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... bmj 370, 2020 | 1010 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 715 | 2021 |
| Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol AB Docherty, EM Harrison, CA Green, H Hardwick, R Pius, L Norman, ... MedRxiv, 2020.04. 23.20076042, 2020 | 430 | 2020 |
| Acute respiratory distress syndrome and acute lung injury A Dushianthan, MPW Grocott, AD Postle, R Cusack Postgraduate medical journal 87 (1031), 612-622, 2011 | 399 | 2011 |
| Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol L Sigfrid, TM Drake, E Pauley, EC Jesudason, P Olliaro, WS Lim, ... The Lancet Regional Health–Europe 8, 2021 | 289 | 2021 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 277 | 2021 |
| Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane Systematic Review MPW Grocott, A Dushianthan, MA Hamilton, MG Mythen, D Harrison, ... British journal of anaesthesia 111 (4), 535-548, 2013 | 235 | 2013 |
| Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study TM Drake, AB Docherty, EM Harrison, JK Quint, H Adamali, S Agnew, ... American journal of respiratory and critical care medicine 202 (12), 1656-1665, 2020 | 221 | 2020 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 189 | 2021 |
| Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery MPW Grocott, A Dushianthan, MA Hamilton, MG Mythen, D Harrison, ... Cochrane Database of Systematic Reviews, 2012 | 188* | 2012 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The Lancet Respiratory Medicine 9 (7), 699-711, 2021 | 164 | 2021 |
| Perioperative buffered versus non‐buffered fluid administration for surgery in adults E Burdett, A Dushianthan, E Bennett‐Guerrero, S Cro, TJ Gan, ... Cochrane Database of Systematic Reviews, 2012 | 150 | 2012 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 142 | 2021 |
| A prenylated dsRNA sensor protects against severe COVID-19 A Wickenhagen, E Sugrue, S Lytras, S Kuchi, M Noerenberg, ML Turnbull, ... Science 374 (6567), eabj3624, 2021 | 139 | 2021 |
| Immunonutrition for acute respiratory distress syndrome (ARDS) in adults A Dushianthan, R Cusack, VA Burgess, MPW Grocott, PC Calder Cochrane Database of Systematic Reviews, 2019 | 117 | 2019 |
| Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome-where do we go from here? A Dushianthan, R Cusack, V Goss, AD Postle, MPW Grocott Critical Care 16, 1-11, 2012 | 103 | 2012 |
| Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021 | 94 | 2021 |
| Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial DF McAuley, LJM Cross, U Hamid, E Gardner, JS Elborn, KM Cullen, ... The Lancet Respiratory Medicine 5 (6), 484-491, 2017 | 90 | 2017 |
Mike GrocottProfessor of Anaesthesia & Critical Care Medicine, University of Southampton / Duke UniversityVerified email at soton.ac.uk
